Shares of Soleno Therapeutics Inc. (SLNO) are down over 20% from their 52-week high of $60.92, recorded last month, and trade around $47.This clinical-stage biopharmaceutical company is developing novel therapeutics for the treatment of rare diseases. Its lead drug candidate is DCCR (diazoxide choline) extended-release tablets, a once-daily oral tablet for treating Prader-Willi syndrome.The Prader...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.